GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Change In Other Working Capital

Accelerated Pharma (Accelerated Pharma) Change In Other Working Capital : $0.00 Mil (TTM As of Mar. 2017)


View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Change In Other Working Capital?

Accelerated Pharma's Change In Other Working Capital for the quarter that ended in Mar. 2017 was $0.00 Mil. It means Accelerated Pharma's Other Working Capital stayed the same from Dec. 2016 to Mar. 2017 .

Accelerated Pharma's Change In Other Working Capital for the fiscal year that ended in Dec. 2016 was $-0.00 Mil. It means Accelerated Pharma's Other Working Capital declined by $0.00 Mil from Dec. 2015 to Dec. 2016 .


Accelerated Pharma Change In Other Working Capital Historical Data

The historical data trend for Accelerated Pharma's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Change In Other Working Capital Chart

Accelerated Pharma Annual Data
Trend Dec14 Dec15 Dec16
Change In Other Working Capital
- - -

Accelerated Pharma Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
Change In Other Working Capital Get a 7-Day Free Trial - - - - -

Accelerated Pharma Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Accelerated Pharma Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Accelerated Pharma (Accelerated Pharma) Business Description

Traded in Other Exchanges
N/A
Address
Website
Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines